In 2004, Dinesh Thakur, a senior employee of Ranbaxy, then India s largest pharma company, discovered a terrible secret. Ranbaxy had been fabricating the test results of their drugs, endangering millions of patients. Thakur resigned and became a whistleblower to the US Food and Drug Administration, one of the regulators Ranbaxy had been lying to, and ultimately brought the multibillion-dollar behemoth to its knees. This is the sensational account of the high-stakes chase to bring Ranbaxy to book and the fall from grace of one of corporate India s biggest success stories. But the rot in Indian pharma isn’t confined to Ranbaxy alone…